PGEN PRECIGEN, INC.

Nasdaq Pharmaceutical Preparations VA CIK: 0001356090
AI RATING
STRONG_SELL
85% Confidence

Investment Thesis

Despite impressive 146.7% revenue growth, PGEN faces critical financial distress with unsustainable cash burn (-$44.1M FCF), severe leverage (4.62x debt-to-equity ratio), and negative interest coverage (-0.5x) indicating inability to service debt from operations. At current burn rate, the company's $7.5M cash position provides less than 1 month of runway, creating immediate solvency risk.

Strengths

  • + Strong revenue growth of 146.7% YoY demonstrates market traction
  • + Excellent liquidity ratios (4.82x current ratio, 4.76x quick ratio) provide near-term payment capacity
  • + Operates in high-growth pharmaceutical sector with innovation potential

Risks

  • ! Catastrophic cash burn of -$43.8M operating cash flow with only $7.5M cash on hand
  • ! Dangerously high leverage (4.62x debt-to-equity, $93.5M long-term debt vs $20.2M equity) with negative interest coverage of -0.5x
  • ! Deteriorating profitability despite revenue growth: net income down 240.4% YoY with -34.1% net margin and -25.8% operating margin, indicating business model is unprofitable at scale

Key Metrics to Watch

Financial Metrics

Revenue
23.3M
Net Income
-7.9M
EPS (Diluted)
$-0.02
Free Cash Flow
-44.1M
Total Assets
138.6M
Cash
7.5M

Profitability Ratios

Gross Margin N/A
Operating Margin -25.8%
Net Margin -34.1%
ROE -39.2%
ROA -5.7%
FCF Margin -189.6%

Balance Sheet & Liquidity

Current Ratio
4.82x
Quick Ratio
4.76x
Debt/Equity
4.62x
Debt/Assets
85.4%
Interest Coverage
-0.46x
Long-term Debt
93.5M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-15T10:00:09.030582 | Data as of: 2026-03-31 | Powered by Claude AI